CoSyne Therapeutics

📍 London, United Kingdom🗓 Founded 2021👥 15 employees💰 Last funded Aug 2026
Biotechnology Research🌐 cosyne.com
Website LinkedIn
CoSyne Therapeutics is a vertically integrated AI Drug Discovery company aiming to bring speed to precision medicine through polymathic AI to help patients with under-served diseases of the brain.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in CoSyne Therapeutics?
CoSyne Therapeutics has 1 investor on record on gritt.io, 1 mid-stage.
When did CoSyne Therapeutics last raise funding?
The most recent investment in CoSyne Therapeutics recorded on gritt.io was in August 2026.
When was CoSyne Therapeutics founded?
CoSyne Therapeutics was founded in 2021.
What industry is CoSyne Therapeutics in?
CoSyne Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is CoSyne Therapeutics based?
CoSyne Therapeutics is headquartered in London, United Kingdom.